No Data
Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%. -- Barrons.com
Top Gap Ups and Downs on Tuesday: HON, SHOP, SE and More
Amgen Slips as Cantor Cites Safety Concerns Linked to Obesity Candidate
10 Health Care Stocks Whale Activity In Today's Session
Decoding Novo Nordisk's Options Activity: What's the Big Picture?
Hims & Hers Health, up 20%, Hits All-time High